Human Chorionic Gonadotropin Market Size And Growth In 2026: Key Factors Shaping Future Demand

Human Chorionic Gonadotropin Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Human Chorionic Gonadotropin Market Forecast: Value Set To Climb From $1.11 Billion To $1.52 Billion

The human chorionic gonadotropin market size has shown significant growth in recent years. It is anticipated to increase from $1.02 billion in 2025 to $1.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. The expansion observed in the past can be linked to the rising occurrence of infertility, an increase in fertility clinics globally, the established clinical application of hCG in reproductive medicine, enhanced understanding of treatments for hormonal imbalances, and the presence of hCG products derived from natural sources.

The human chorionic gonadotropin market is projected to experience robust expansion over the coming years, anticipated to reach $1.52 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.2%. This growth during the forecast period can be attributed to several factors, including the increasing demand for assisted reproductive technologies, greater adoption of recombinant hormones, an expanding emphasis on precision fertility treatments, the widening reach of online and retail pharmacy distribution, and heightened investment in reproductive health research. Furthermore, key trends expected throughout the forecast period involve the expanded utilization of hCG in assisted reproductive treatments, a surge in demand for hormonal therapies to manage infertility, the growing acceptance of recombinant hCG products, the broadening of hCG applications for male hormonal disorders, and an enhanced focus on developing standardized and high-purity hormone formulations.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=20799294&type=smp&name=Human%20Chorionic%20Gonadotropin%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Human Chorionic Gonadotropin Market Growth Drivers: What’s Behind The Acceleration?

The rising prevalence of infertility is anticipated to propel the expansion of the human chorionic gonadotropin market in the future. Infertility is defined as the inability to achieve pregnancy after a minimum of one year of regular, unprotected sexual activity. This rate is escalating as more individuals and couples encounter challenges in conception, attributed to factors such as postponing parenthood, shifts in lifestyle, exposure to environmental elements, and underlying health issues. Human chorionic gonadotropin (hCG) serves as a treatment for infertility, aiding in stimulating ovulation in women and boosting testosterone production in men, thereby promoting egg release and enhancing fertility results. For example, data from April 2023 by the World Health Organization, a Switzerland-based intergovernmental body, indicated that approximately 17.5% of the global adult population, or about one in six individuals, were impacted by infertility, underscoring the vital demand for more affordable and quality fertility services. Consequently, the increasing rate of infertility is a key factor boosting the growth of the human chorionic gonadotropin market. The expanding elderly demographic is projected to stimulate the growth of the human chorionic gonadotropin market in the coming years. An aging population signifies a societal trend where the proportion of older people increases, primarily due to longer life expectancies and decreased birth rates. This demographic shift is accelerating because healthcare improvements have led to extended lifespans. Human chorionic gonadotropin (hCG) is utilized by older adults to aid in balancing hormones and sustaining testosterone levels. For instance, the Population Reference Bureau, a US-based non-profit, stated in January 2024 that the population of Americans aged 65 and above is projected to climb from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Consequently, this age bracket’s share of the total U.S. population will expand from 17% to 23% within this timeframe. Thus, the increasing aging population is a significant factor propelling the expansion of the human chorionic gonadotropin market.

Human Chorionic Gonadotropin Market Segments: Where Is Growth Concentrated?

The human chorionic gonadotropin market covered in this report is segmented –

1) By Technology: Natural Source Extraction, Recombinant Technology

2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Fertility Clinics, Research Institutions, Other End Users

Subsegments:

1) By Natural Source Extraction: Extraction From Pregnant Women’s Urine, Purified Urinary hCG (u-hCG) Formulations

2) By Recombinant Technology: Recombinant Hcg, Recombinant Hcg For Therapeutic Use, Recombinant Hcg For Diagnostic Applications

Human Chorionic Gonadotropin Market Key Participants And Competitive Landscape

Major companies operating in the human chorionic gonadotropin market are Ferring Pharmaceuticals, Merck KGaA, Organon, IBSA Institut Biochimique, Teva Pharmaceutical Industries, Sandoz, Sun Pharmaceutical Industries, Cipla, Zydus Lifesciences, Lupin, Intas Pharmaceuticals, Hikma Pharmaceuticals, Aspen Pharmacare, Menarini Group, Bharat Serums and Vaccines, Serum Institute of India, LG Chem Life Sciences, Dong-A ST, Livzon Pharmaceutical Group, SciGen

View The Full Human Chorionic Gonadotropin Market Report:

https://thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Human Chorionic Gonadotropin Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the human chorionic gonadotropin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model